ebola disease
DESCRIPTION
Ebola virus - basic approach and managementTRANSCRIPT
![Page 1: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/1.jpg)
![Page 2: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/2.jpg)
2
WHAT IS EBOLA VIRUS? The genus Ebolavirus is a virological
taxon included in the family Filoviridae, order Mononegavirales.
The species in this genus are called ebolaviruses. Five species are known, and four of these cause Ebola virus disease in humans.
The name Ebolavirus is derived from the Ebola River in Zaire (now the Democratic Republic of the Congo), where Ebola virus was first discovered.
![Page 3: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/3.jpg)
3
- Characteristics of Filoviruses: - Filamentous form with a uniform diameter of approximately 80 nm but display great variation in length. - Nonsegmented negative-stranded RNA genome containing 7 structural and regulatory genes.
![Page 4: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/4.jpg)
Group: Group V (-)ssRNA. Order:Mononegavirales
Family:Filoviridae Genus:Ebolavirus
Virus Classification
![Page 5: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/5.jpg)
![Page 6: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/6.jpg)
![Page 7: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/7.jpg)
First isolated in 1976 in Zaire and Sudan.
Ebola Hemorrhagic Fever was first found in 1976 It struck two countries within that year a. Sudan – in a town called N’zara b. Zaire, now known as the Democratic Republic of Congo In these two instances the mortality rate was between 50 –90%
Following those epidemics, Ebola hit Africa in many other instances the worst yet being in the year 2000 when it struck Uganda infecting more than 400 people.
Biosafety level 4 agent, as well as a Category A bioterrorism agent
History
![Page 8: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/8.jpg)
Zaire Sudan Côte d'Ivoire Bundibugyo Reston
Subtypes
![Page 9: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/9.jpg)
single linear negative-sense, single-stranded RNA
lipid envelope. destroyed by heat (60°C, 30 min), acidity
Structure
![Page 10: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/10.jpg)
Nonhuman primates
Fruit bats
Reservoir
![Page 11: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/11.jpg)
Person-to-person (secretions) Exposure to bats (Pteropodidae family) Nosocomial transmission Accidental infection of workers in any
Biosafety-Level-4 Use of filoviruses as biological weapons
Transmission
![Page 12: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/12.jpg)
![Page 13: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/13.jpg)
![Page 14: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/14.jpg)
•Virus enters the body via infected blood/body fluid in contact with a mucosal surface or a break in intact skin.
•Virus replicates preferentially in monocytes/macrophages and dendritic cells which facilitate dissemination of the virus throughout the body via lymphatic system.
•Other cells are secondarily infected and there is rapid viral growth in hepatocytes, endothelial and epithelial tissues.
•There is strong cytokine/inflammatory mediator release of TNF-a and inflammatory cascade.
Pathogenesis - how does Ebola cause disease?
![Page 15: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/15.jpg)
•Leads to endothelial damage, increased vascular permeability and shock.
•This results in the end organ damage and multi-organ dysfunction
•Diffuse intravascular coagulopathy(DIC) with platelet and coagulation factor consumption which leads to hemorrhage.
•IgM starts forming in 2 day and IgG in 5-8 days post infection. Immunologic response correlates with survival.
•Thus the observation that those who live >1 week are more likely to survive.
![Page 16: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/16.jpg)
Pathogenesis
![Page 17: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/17.jpg)
Incubation period of 7–10 days (range, 3–16 days abrupt onset of fever, chills, and general malaise weakness, headache, myalgia, nausea, vomiting,
diarrhea, and abdominal pain relative bradycardia nonproductive cough and pharyngitis, with the
sensation of a lump or "ball" in the throat non pruritic maculopapular rash on the upper
body
Signs and symptoms
![Page 18: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/18.jpg)
![Page 19: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/19.jpg)
![Page 20: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/20.jpg)
reddening of eyes petechiae, purpura, ecchymoses,
and hematomas (especially around needle injection sites).
impaired blood clotting. bleeding from mucous
membranes (e.g. gastrointestinal tract, nose, vagina and gums) is reported in 40–50% of cases.
Bleeding phase
![Page 21: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/21.jpg)
![Page 22: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/22.jpg)
Leukopenia , neutropenia, thrombocytopenia
Increased AST and ALT Protienuria
Labaratory findings
![Page 23: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/23.jpg)
DIAGNOSIS
![Page 24: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/24.jpg)
treatment
supportive therapy.
• balancing the patient’s fluids and electrolytes• maintaining their oxygen status and blood
pressure• treating them for any complicating infections• correction of severe coagulopathy
![Page 25: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/25.jpg)
Zmapp -combination of three different monoclonal antibodies
Vaccines in phase 1 trials
![Page 26: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/26.jpg)
wearing of protective clothing (such as masks, gloves, gowns, and goggles)
the use of infection-control measures (such as complete equipment sterilization and routine use of disinfectant)
isolation of Ebola HF patients from contact with unprotected persons.
prevention
![Page 27: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/27.jpg)
Guinea, Sierra Leone, Liberia, and Nigeria
Current outbreak
![Page 28: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/28.jpg)
In March 2014, the World Health Organization (WHO) reported a major Ebola outbreak in Guinea, a western African nation; it is the largest ever documented, and the first recorded in the region. Researchers traced the outbreak to a two-year old child who died on 6 December 2013.
On 8 August 2014, the WHO declared the epidemic to be an international public health emergency.
By 6 September 2014, 4,293 suspected cases including 2,296 deaths had been reported.
![Page 29: Ebola disease](https://reader035.vdocument.in/reader035/viewer/2022070413/55cf92c0550346f57b99407c/html5/thumbnails/29.jpg)
Medscape
NEJM – Ebola -A Growing Threat? Heinz Feldmann, M.D. May 7, 2014DOI: 10.1056/NEJMp1405314
CDC
Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet. 2011 Mar 5;377(9768):849-62.
WHO: EBOLA RESPONSE ROADMAP UPDATE
Isaacson, M; Sureau, P; Courteille, G; Pattyn, SR;. Clinical Aspects of Ebola Virus Disease at the Ngaliema Hospital, Kinshasa, Zaire, 1976. Retrieved 2009-07-08.
Wikipedia
References